Clinical Study
Chronic Kidney Disease Stage Is a Modulator on the Association between High-Sensitivity C-Reactive Protein and Coronary Vasospastic Angina
Table 4
Univariate analysis of variables associated with coronary vasospasm in the study patients.
| Variables | All patients | CKD stage 1 | CKD stage 2 | CKD stage 3 | | | | | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value |
| Age, years | 1.02 | 1.008–1.031 | 0.001 | 1.041 | 1.015–1.067 | 0.002 | 1.019 | 1.003–1.035 | 0.019 | 1.017 | 0.947–1.041 | 0.701 | Men versus women | 2.429 | 1.835–3.215 | <0.001 | 2.431 | 1.778–3.324 | <0.001 | 2.245 | 1.529–3.297 | <0.001 | 2.668 | 1.360–5.234 | 0.004 | Smoker (yes versus no) | 2.48 | 1.849–3.326 | <0.001 | 2.655 | 1.920–3.672 | <0.001 | 2.355 | 1.595–3.475 | <0.001 | 1.794 | 0.895–3.598 | 0.1 | Peripheral white blood cell count, /1000 mm3 | 1.244 | 1.143–1.353 | <0.001 | 1.221 | 1.112–1.339 | <0.001 | 1.21 | 1.087–1.347 | 0.001 | 1.356 | 1.098–1.675 | 0.005 | Peripheral monocyte blood cell count, /mm3 | 1.003 | 1.002–1.003 | <0.001 | 1.003 | 1.002–1.004 | <0.001 | 1.002 | 1.001–1.003 | <0.001 | 1.002 | 1.001–1.004 | 0.007 | Haemoglobin, g/dL | 1.152 | 1.045–1.271 | 0.004 | 1.147 | 1.026–1.283 | 0.016 | 1.141 | 0.998–1.304 | 0.053 | 1.207 | 0.970–1.502 | 0.091 | eGFR, mL/min/1.73 m2 | 0.997 | 0.991–1.003 | 0.36 | 0.984 | 0.975–0.994 | 0.001 | 0.992 | 0.983–1.001 | 0.075 | 0.986 | 0.966–1.006 | 0.175 | hs-CRP, mg/L | 1.133 | 1.067–1.202 | <0.001 | 1.15 | 1.070–1.236 | <0.001 | 1.186 | 1.078–1.304 | <0.001 | 1.09 | 0.987–1.204 | 0.089 |
|
|
Statistical significance based on binary logistic regression analysis. CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate; hs-CRP: high-sensitivity C-reactive protein.
|